Steadcast
The Top Line cover art

The Top Line

Fierce Life Sciences

Fierce Biotech and Pharma journalists break down weekly biopharma and medtech business news.

Why we picked this

We picked The Top Line for its no-nonsense weekly accounting of biopharma and medtech business. Three Fierce journalists track mergers, R&D pipelines, and regulatory shifts with a practitioner’s eye for how policy hits the income statement. The show trades hype for operational specifics—supply-chain margins, tariff exposure, the capital consequences of drug-pricing reform. Listeners who want industry logic, not health-technology boosterism, will find the feed earns its weekly slot.

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.

HealthBusiness12 episodes on Steadcast · Latest Jun 2026

Recent episodes

Ipsen R&D chief on pipeline discipline, partnerships and 2026 milestones

Jun 12, 202615 min

Behind the headlines of ASCO 2026

Jun 5, 202629 min

Mesutoclax points to possible shift in high-risk MDS and AML (Sponsored)

Jun 3, 202621 min

Boston, China and the future of biotech

May 29, 202635 min

Why direct-to-patient is the future of pharma access (Sponsored)

May 28, 20269 min

BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions

May 22, 202612 min

Designing an agentic, future‑ready tech roadmap for emerging pharma (Sponsored)

May 18, 202628 min

Health execs persevere in new policy landscape

May 15, 202622 min

Revisiting Pharma’s tariff reality

May 8, 202615 min

Setting a new standard in prefillable syringe systems (Sponsored)

May 7, 202612 min

Scaling theranostics through access, safety and trust (Sponsored)

May 4, 20267 min

A pivotal time for an RNA pioneer

May 1, 202635 min

Related shows